NCT06169982CompletedPhase 1
A study to assess the pharmacokinetics, and glucodynamics of LY3209590 in participants with type 2 diabetes
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Mar 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 29 Sept 2023
- Start date
- 5 Dec 2023
- Lead sponsor
- Eli Lilly & Co.
- Diseases
- Type 1 diabetes, Type 2 diabetes
- EU CT number
- 2023-508008-39-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 70
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PROFIL Institut fuer Stoffwechselforschung GmbH Coordinator of this site? Confirm its status | Neuss | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.